Literature DB >> 25134928

A bifunctional curcumin analogue for two-photon imaging and inhibiting crosslinking of amyloid beta in Alzheimer's disease.

Xueli Zhang1, Yanli Tian, Peng Yuan, Yuyan Li, Mohammad A Yaseen, Jaime Grutzendler, Anna Moore, Chongzhao Ran.   

Abstract

In this report, we designed a highly bright bifunctional curcumin analogue CRANAD-28. In vivo two-photon imaging suggested that CRANAD-28 could penetrate the blood brain barrier (BBB) and label plaques and cerebral amyloid angiopathies (CAAs). We also demonstrated that this imaging probe could inhibit the crosslinking of amyloid beta induced either by copper or by natural conditions.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25134928      PMCID: PMC4617557          DOI: 10.1039/c4cc03731f

Source DB:  PubMed          Journal:  Chem Commun (Camb)        ISSN: 1359-7345            Impact factor:   6.222


  37 in total

Review 1.  Covalent and noncovalent phthalocyanine-carbon nanostructure systems: synthesis, photoinduced electron transfer, and application to molecular photovoltaics.

Authors:  Giovanni Bottari; Gema de la Torre; Dirk M Guldi; Tomás Torres
Journal:  Chem Rev       Date:  2010-04-05       Impact factor: 60.622

2.  A craniotomy surgery procedure for chronic brain imaging.

Authors:  Ricardo Mostany; Carlos Portera-Cailliau
Journal:  J Vis Exp       Date:  2008-02-15       Impact factor: 1.355

3.  Heme binding induces dimerization and nitration of truncated β-amyloid peptide Aβ16 under oxidative stress.

Authors:  Grégory Thiabaud; Silvia Pizzocaro; Ricardo Garcia-Serres; Jean-Marc Latour; Enrico Monzani; Luigi Casella
Journal:  Angew Chem Int Ed Engl       Date:  2013-06-20       Impact factor: 15.336

4.  PET-FCS: probing rapid structural fluctuations of proteins and nucleic acids by single-molecule fluorescence quenching.

Authors:  Markus Sauer; Hannes Neuweiler
Journal:  Methods Mol Biol       Date:  2014

5.  Spectral unmixing imaging of wavelength-responsive fluorescent probes: an application for the real-time report of amyloid Beta species in Alzheimer's disease.

Authors:  Chongzhao Ran; Anna Moore
Journal:  Mol Imaging Biol       Date:  2012-06       Impact factor: 3.488

6.  Mechanisms of quenching of Alexa fluorophores by natural amino acids.

Authors:  Huimin Chen; Syed S Ahsan; Mitk'El B Santiago-Berrios; Hector D Abruña; Watt W Webb
Journal:  J Am Chem Soc       Date:  2010-06-02       Impact factor: 15.419

7.  Resolving controversies on the path to Alzheimer's therapeutics.

Authors:  Dennis J Selkoe
Journal:  Nat Med       Date:  2011-09-07       Impact factor: 53.440

Review 8.  Nanoparticle-based theranostic agents.

Authors:  Jin Xie; Seulki Lee; Xiaoyuan Chen
Journal:  Adv Drug Deliv Rev       Date:  2010-08-04       Impact factor: 15.470

9.  Copper mediates dityrosine cross-linking of Alzheimer's amyloid-beta.

Authors:  Craig S Atwood; George Perry; Hong Zeng; Yoji Kato; Walton D Jones; Ke-Qing Ling; Xudong Huang; Robert D Moir; Dandan Wang; Lawrence M Sayre; Mark A Smith; Shu G Chen; Ashley I Bush
Journal:  Biochemistry       Date:  2004-01-20       Impact factor: 3.162

10.  Non-conjugated small molecule FRET for differentiating monomers from higher molecular weight amyloid beta species.

Authors:  Chongzhao Ran; Wei Zhao; Robert D Moir; Anna Moore
Journal:  PLoS One       Date:  2011-04-29       Impact factor: 3.240

View more
  19 in total

1.  Near-infrared fluorescence molecular imaging of amyloid beta species and monitoring therapy in animal models of Alzheimer's disease.

Authors:  Xueli Zhang; Yanli Tian; Can Zhang; Xiaoyu Tian; Alana W Ross; Robert D Moir; Hongbin Sun; Rudolph E Tanzi; Anna Moore; Chongzhao Ran
Journal:  Proc Natl Acad Sci U S A       Date:  2015-07-21       Impact factor: 11.205

2.  A comparative study of dietary curcumin, nanocurcumin, and other classical amyloid-binding dyes for labeling and imaging of amyloid plaques in brain tissue of 5×-familial Alzheimer's disease mice.

Authors:  Panchanan Maiti; Tia C Hall; Leela Paladugu; Nivya Kolli; Cameron Learman; Julien Rossignol; Gary L Dunbar
Journal:  Histochem Cell Biol       Date:  2016-07-12       Impact factor: 4.304

Review 3.  Microglia-Mediated Neuroprotection, TREM2, and Alzheimer's Disease: Evidence From Optical Imaging.

Authors:  Carlo Condello; Peng Yuan; Jaime Grutzendler
Journal:  Biol Psychiatry       Date:  2017-10-14       Impact factor: 13.382

Review 4.  Targeting β-amyloid plaques and oligomers: development of near-IR fluorescence imaging probes.

Authors:  Hongwu Liu; Jian Yang; Letian Wang; Yungen Xu; Siyuan Zhang; Jie Lv; Chongzhao Ran; Yuyan Li
Journal:  Future Med Chem       Date:  2017-01-27       Impact factor: 3.808

Review 5.  Advances in development of fluorescent probes for detecting amyloid-β aggregates.

Authors:  Ming-Ming Xu; Wen-Ming Ren; Xi-Can Tang; You-Hong Hu; Hai-Yan Zhang
Journal:  Acta Pharmacol Sin       Date:  2016-03-21       Impact factor: 6.150

Review 6.  Curcumin in Health and Diseases: Alzheimer's Disease and Curcumin Analogues, Derivatives, and Hybrids.

Authors:  Eirini Chainoglou; Dimitra Hadjipavlou-Litina
Journal:  Int J Mol Sci       Date:  2020-03-13       Impact factor: 5.923

7.  Oxalate-curcumin-based probe for micro- and macroimaging of reactive oxygen species in Alzheimer's disease.

Authors:  Jian Yang; Xueli Zhang; Peng Yuan; Jing Yang; Yungen Xu; Jaime Grutzendler; Yihan Shao; Anna Moore; Chongzhao Ran
Journal:  Proc Natl Acad Sci U S A       Date:  2017-11-06       Impact factor: 11.205

Review 8.  Chalcone and its analogs: Therapeutic and diagnostic applications in Alzheimer's disease.

Authors:  Pritam Thapa; Sunil P Upadhyay; William Z Suo; Vikas Singh; Prajwal Gurung; Eung Seok Lee; Ram Sharma; Mukut Sharma
Journal:  Bioorg Chem       Date:  2021-01-29       Impact factor: 5.307

9.  Microglia constitute a barrier that prevents neurotoxic protofibrillar Aβ42 hotspots around plaques.

Authors:  Carlo Condello; Peng Yuan; Aaron Schain; Jaime Grutzendler
Journal:  Nat Commun       Date:  2015-01-29       Impact factor: 14.919

10.  Discovery of novel PDE9 inhibitors capable of inhibiting Aβ aggregation as potential candidates for the treatment of Alzheimer's disease.

Authors:  Tao Su; Tianhua Zhang; Shishun Xie; Jun Yan; Yinuo Wu; Xingshu Li; Ling Huang; Hai-Bin Luo
Journal:  Sci Rep       Date:  2016-02-25       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.